CIK 0001041024 · Non-accelerated filer<br>Smaller reporting company
ROCKWELL MEDICAL, INC.
Sign in to watch- Ticker
- RMTI
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 383317208
- Phone
- 8004493353
- Business address
- 30142 WIXOM ROAD, WIXOM, MI, 48393
- Former names
- ROCKWELL MEDICAL TECHNOLOGIES INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $8,420
- in 1 filing, $8K under 10b5-1 plans
Net −$8,420. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-17 | Hoffman Marc L Chief Medical Officer | Grant or award | +25,665 | 25,665 | ||
| 2023-03-17 | Hoffman Marc L Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +32,990 | 32,990 | ||
| 2023-03-17 | Strobeck Mark President and CEO | Grant or award | +55,465 | 55,465 | ||
| 2023-03-17 | Strobeck Mark President and CEO | Grant or award · Stock Option (Right to Buy) | +77,105 | 77,105 | ||
| 2023-03-17 | McGarry Paul E SVP, Finance and CAO | Grant or award | +28,515 | 28,515 | ||
| 2023-03-17 | McGarry Paul E SVP, Finance and CAO | Grant or award · Stock Option (Right to Buy) | +37,210 | 37,210 | ||
| 2022-09-09 | Hoffman Marc L Chief Medical Officer | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2022-09-09 | TIMMINS MEGAN C. SVP, General Counsel | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-09-09 | McGarry Paul E VP, Finance | Grant or award · Stock Option (Right to Buy) | +60,000 | 60,000 | ||
| 2022-09-09 | SKIBSTED RUSSELL See Remarks | Grant or award · Stock Option (Right to Buy) | +80,000 | 80,000 | ||
| 2022-07-01 | Strobeck Mark President and CEO | Grant or award · Stock Option (Right to Buy) | +400,000 | 400,000 | ||
| 2022-06-07 | Radie Robert S Director | Grant or award | +25,000 | 109,689 | ||
| 2022-06-07 | RAVICH MARK H Director | Grant or award | +25,000 | 278,604 | ||
| 2022-06-07 | COOPER JOHN G Director | Grant or award | +25,000 | 130,879 | ||
| 2022-06-07 | Smiley Andrea Heslin Director | Grant or award | +25,000 | 93,601 | ||
| 2022-06-07 | Nissenson Allen Director | Grant or award | +25,000 | 99,488 | ||
| 2022-03-17 | TIMMINS MEGAN C. EVP, CLO and Secretary | Grant or award · Stock Option (Right to Buy) | +37,210 | 37,210 | ||
| 2021-08-16 | TIMMINS MEGAN C. See Remarks | Grant or award · Stock Option (Right to Buy) | +350,000 | 350,000 | ||
| 2021-06-17 | RAVICH MARK H Director | Grant or award | +50,000 | 253,604 | ||
| 2021-06-17 | RAVICH MARK H Director | Grant or award · Stock Option (Right to Buy) | +72,857 | 72,857 |
Page 7 of 8 · 153 trades